drugset

drugset / Trial / NCT00004033

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

NCT00004033 ↗

Phase 2 Completed 30 enrolled NYU Langone Health National Cancer Institute (NCI) · collab

Treatment

Summary

RATIONALE: Patient abstract not available PURPOSE: Patient abstract not available

Timeline

Start: 1998-09
Primary completion: 2001-05
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NDDP	Unknown	—	—

Indications